Kurt Mueller is a Generative AI expert and Chief Digital Officer, recognized as a thought leader in digital strategy, omnichannel marketing, CRM, and interactive communications. He has extensive experience guiding pharmaceutical, biotechnology, medical device, and rare disease clients—including Abbott Nutrition, AbbVie, Allergan, Alexion, Bristol-Myers Squibb, Novartis, Pfizer, Sanofi, and Takeda—across product promotion, medical communications, and lifecycle management.
Kurt’s therapeutic expertise spans dermatology, endocrinology, gastroenterology, hematology, immunology, neurology, renal transplant, rheumatology, and radiopharmaceuticals, covering prelaunch, launch, post-launch, franchise, and lifecycle strategies. Known for transforming underperforming digital teams into high-performing, agile organizations, he consistently drives significant financial results and ROI.
A passionate advocate for Generative AI, Kurt serves as Managing Director, Digital & AI at a leading life sciences agency, and has earned his AI in Healthcare certification from Stanford University. He has authored multiple AI-focused industry publications and is a sought-after speaker at events including SPARK 2024, Transperfect C3 Summit, ePatient Connections, Digital Pharma West, and PanAgora Pharma. Recognized as a Top 5 Marketer by PharmaVOICE and a Top Innovator by PM360, he also serves on the PM360 editorial advisory board.